Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0000905148-25-003155

Director sold 10,684 shares at $2.09 ($22,378)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hemrajani Rekha Director 2025-06-25 Sale 10b5-1 −10,684 $2.09 $22,378 39,893 D: show line 1 in the form
Open-market sales · 10,684 sh · avg $2.09 · $22,378
Loading xslF345X05/form4.xml…